☆ 4.7 Article

Structural and molecular cholinergic imaging markers of cognitive decline in Parkinson's disease

BRAIN (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Clinical Neurology

Atrophy of the Cholinergic Basal Forebrain can Detect Presynaptic Cholinergic Loss in Parkinson's Disease

Nicola J. J. Ray et al.

Summary: Structural imaging of the cholinergic basal forebrain may provide a biomarker for cholinergic system integrity in Parkinson's disease. This study validates the correlation between cholinergic basal forebrain morphometry and vesicular acetylcholine transporter in a large Parkinson's sample.

ANNALS OF NEUROLOGY (2023)

添加到收藏夹

Article Clinical Neurology

Altered Cholinergic Innervation in De Novo Parkinson's Disease with and without Cognitive Impairment

Sygrid van der Zee et al.

Summary: This study assessed the cholinergic innervation status in early-stage Parkinson's disease (PD) patients and found that cholinergic innervation changes were associated with cognitive impairment. Regardless of cognitive status, patients showed cholinergic denervation in the posterior cortical regions. Cognitively intact patients exhibited higher cholinergic activity in the cerebellar, frontal, and subcortical regions, suggesting compensatory cholinergic upregulation in early-stage PD. Limited or failing cholinergic upregulation may play an important role in early cognitive impairment in PD.

MOVEMENT DISORDERS (2022)

添加到收藏夹

Article Neurosciences

Mapping Cholinergic Synaptic Loss in Parkinson's Disease: An [18F]FEOBV PET Case-Control Study

Jacob Horsager et al.

Summary: Cholinergic degeneration is strongly associated with cognitive decline and motor symptoms in Parkinson's disease (PD). This study found prominent cortical cholinergic degeneration in non-demented PD patients, but more subtle degeneration in subcortical structures. Regional differences in cholinergic alterations may reflect disease progression patterns.

JOURNAL OF PARKINSONS DISEASE (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Parkinson's disease in women: Mechanisms underlying sex differences

Bhupesh Vaidya et al.

Summary: Parkinson's disease is less prevalent in women compared to men, but this difference tends to diminish with age. Various genetic, hormonal, and molecular factors contribute to the differences in the pathogenesis of Parkinson's disease.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

添加到收藏夹

Article Clinical Neurology

In vivo cholinergic basal forebrain degeneration and cognition in Parkinson's disease: Imaging results from the COPPADIS study

Michel J. Grothe et al.

Summary: Early cognitive deficits in PD without dementia are more closely related to structural MRI measures of CBF degeneration than hippocampal degeneration.

PARKINSONISM & RELATED DISORDERS (2021)

添加到收藏夹

Article Medicine, General & Internal

Parkinson disease-associated cognitive impairment

Dag Aarsland et al.

Summary: Cognitive impairment is common in Parkinson disease patients, with varying degrees of severity, emphasizing the importance of early identification and treatment.

NATURE REVIEWS DISEASE PRIMERS (2021)

添加到收藏夹

Article Clinical Neurology

Cholinergic Denervation Patterns Across Cognitive Domains in Parkinson's Disease

Sygrid van der Zee et al.

Summary: This study investigated the relationship between cognitive functioning and regional cholinergic innervation in patients with PD, utilizing [F-18]Fluoroethoxybenzovesamicol positron emission tomography imaging. The results showed partial overlapping topography across cognitive domains, with most robust correlations in the domains of memory, attention, and executive functioning. The findings confirm and expand on previous observations of cholinergic system involvement in cognitive functioning in PD, reflecting a combination of disease-specific and aging effects.

MOVEMENT DISORDERS (2021)

添加到收藏夹

Article Neurosciences

Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's disease

Joana B. Pereira et al.

NEUROBIOLOGY OF DISEASE (2020)

添加到收藏夹

Article Neuroimaging

Brain degeneration in Parkinson's disease patients with cognitive decline: a coordinate-based meta-analysis

Alexander S. Mihaescu et al.

BRAIN IMAGING AND BEHAVIOR (2019)

添加到收藏夹

Letter Clinical Neurology

[18F]Fluoroethoxybenzovesamicol in Parkinson's disease patients: Quantification of a novel cholinergic positron emission tomography tracer

Sygrid van der Zee et al.

MOVEMENT DISORDERS (2019)

添加到收藏夹

Article Clinical Neurology

Lower volume, more impairment: reduced cholinergic basal forebrain grey matter density is associated with impaired cognition in Parkinson disease

Matthew J. Barrett et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)

添加到收藏夹

Article Neurosciences

The corticotopic organization of the human basal forebrain as revealed by regionally selective functional connectivity profiles

Hans-Christian J. Fritz et al.

HUMAN BRAIN MAPPING (2019)

添加到收藏夹

Article Clinical Neurology

Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease

Jonathan Schulz et al.

BRAIN (2018)

添加到收藏夹

Article Psychology, Mathematical

Bayesian inference for psychology. Part I: Theoretical advantages and practical ramifications

Eric-Jan Wagenmakers et al.

PSYCHONOMIC BULLETIN & REVIEW (2018)

添加到收藏夹

Article Clinical Neurology

In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease

Nicola J. Ray et al.

BRAIN (2018)

添加到收藏夹

Article Clinical Neurology

Reference standard space hippocampus labels according to the European Alzheimer's Disease Consortium-Alzheimer's Disease Neuroimaging Initiative harmonized protocol: Utility in automated volumetry

Dominik Wolf et al.

ALZHEIMERS & DEMENTIA (2017)

添加到收藏夹

Article Neurosciences

Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment

Michel J. Grothe et al.

CEREBRAL CORTEX (2016)

添加到收藏夹

Article Clinical Neurology

Frequency of Cholinergic and Caudate Nucleus Dopaminergic Deficits Across the Predemented Cognitive Spectrum of Parkinson Disease and Evidence of Interaction Effects

Nicolaas I. Bohnen et al.

JAMA NEUROLOGY (2015)

添加到收藏夹

Article Neurosciences

Subregional Basal Forebrain Atrophy in Alzheimer's Disease: A Multicenter Study

Ingo Kilimann et al.

JOURNAL OF ALZHEIMERS DISEASE (2014)

添加到收藏夹

Article Endocrinology & Metabolism

Heterogeneity of cholinergic denervation in Parkinson's disease without dementia

Nicolaas I. Bohnen et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)

添加到收藏夹

Article Geriatrics & Gerontology

Cognitive Impairment in Parkinson Disease: Impact on Quality of Life, Disability, and Caregiver Burden

Iracema Leroi et al.

JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2012)

添加到收藏夹

Article Mathematics, Interdisciplinary Applications

Default Bayes factors for ANOVA designs

Jeffrey N. Rouder et al.

JOURNAL OF MATHEMATICAL PSYCHOLOGY (2012)

添加到收藏夹

Article Clinical Neurology

Grey matter atrophy in cognitively impaired Parkinson's disease

Tracy R. Melzer et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)

添加到收藏夹

Article Clinical Neurology

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

Irene Litvan et al.

MOVEMENT DISORDERS (2012)

添加到收藏夹

Article Clinical Neurology

Hippocampal abnormalities and memory deficits in Parkinson disease A multimodal imaging study

G. A. Carlesimo et al.

NEUROLOGY (2012)

添加到收藏夹

Article Clinical Neurology

Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo

J. C. Klein et al.

NEUROLOGY (2010)

添加到收藏夹

Article Clinical Neurology

Cognitive impairment in incident, untreated Parkinson disease The Norwegian ParkWest Study

D. Aarsland et al.

NEUROLOGY (2009)

添加到收藏夹

Article Clinical Neurology

Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET

H. Shimada et al.

NEUROLOGY (2009)

添加到收藏夹

Article Clinical Neurology

The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years

Mariese A. Hely et al.

MOVEMENT DISORDERS (2008)

添加到收藏夹

Article Neurosciences

Stereotaxic probabilistic maps of the magnocellular cell groups in human basal forebrain

Laszlo Zaborszky et al.

NEUROIMAGE (2008)

添加到收藏夹

Article Neurosciences

An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest

Rahul S. Desikan et al.

NEUROIMAGE (2006)

添加到收藏夹

Article Clinical Neurology

Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia

NI Bohnen et al.

JOURNAL OF NEUROLOGY (2006)

添加到收藏夹

Article Clinical Neurology

Measurement of basal forebrain atrophy in Alzheimer's disease using MRI

SJ Teipel et al.

BRAIN (2005)

添加到收藏夹

Article Endocrinology & Metabolism

Kinetic analysis of [11C]MP4A using a high-radioactivity brain region that represents an integrated input function for measurement of cerebral acetylcholinesterase activity without arterial blood sampling

S Nagatsuka et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2001)

添加到收藏夹

Review Ophthalmology

Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review

Evita Evangelia Christou et al.

Summary: The retina may serve as a predictive factor for neurodegenerative disorders, with recent use of Optical Coherence Tomography Angiography (OCT-A) in studying macular microcirculation changes in Parkinson's disease (PD). While preliminary evidence suggests OCT-A could be a useful biomarker for cerebral vasculature in PD, further research is needed to confirm its predictive value in clinical practice.

SEMINARS IN OPHTHALMOLOGY

添加到收藏夹

© Peeref 2019-2024. All rights reserved.